Preparation and investigation of mefenamic acid - polyethylene glycol - sucrose ester solid dispersions

被引:9
作者
Fueloep, Ibolya [1 ]
Gyeresi, Arpad [1 ]
Kiss, Lorand [2 ]
Deli, Maria A. [2 ]
Croitoru, Mircea Dumitru [1 ]
Szabo-Revesz, Piroska [3 ]
Aigner, Zoltan [3 ]
机构
[1] Univ Med & Pharm Tirgu Mures, Targu Mures 540139, Romania
[2] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary
[3] Univ Szeged, Fac Pharm, Dept Pharmaceut Technol, H-6720 Szeged, Hungary
关键词
mefenamic acid; sucrose esters; PEG; 6000; solid dispersion; Caco-2; cells; SOLUBILITY-PERMEABILITY INTERPLAY; DISSOLUTION PROFILES; POLYMORPHS I; BIOAVAILABILITY; BEHAVIOR; DRUGS;
D O I
10.1515/acph-2015-0035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mefenamic acid (MA) is a widely used non-steroidal anti-inflammatory (NSAID) drug. The adverse effects typical of NSAIDs are also present in the case of MA, partly due to its low water solubility. The aim of this study was to increase the water solubility of MA in order to influence its absorption and bioavailability. Solid dispersions of MA were prepared by the melting method using polyethylene glycol 6000 and different types (laurate, D-1216; palmitate, P-1670; stearate, S-1670) and amounts of sucrose esters as carriers. The X-ray diffraction results show that MA crystals were not present in the products. Dissolution tests carried out in artificial intestinal juice showed that the product containing 10 % D-1216 increased water solubility about 3 times. The apparent permeability coefficient of MA across human Caco-2 intestinal epithelial cell layers was high and, despite the difference in solubility, there was no further increase in drug penetration in the presence of the applied additives.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 30 条
[1]   THEORETICAL AND EXPERIMENTAL STUDIES OF TRANSPORT OF MICELLE-SOLUBILIZED SOLUTES [J].
AMIDON, GE ;
HIGUCHI, WI ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (01) :77-84
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]  
[Anonymous], 2013, EUROPEAN PHARMACOPOE, P288
[4]  
[Anonymous], RYOT SUG EST TECHN I
[5]  
[Anonymous], TURK J PHARM SCI
[6]   NON-CELIAC FLAT JEJUNAL MUCOSA [J].
BATT, M .
GUT, 1989, 30 :67-68
[7]   Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations [J].
Beig, Avital ;
Agbaria, Riad ;
Dahan, Arik .
PLOS ONE, 2013, 8 (07)
[8]   Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption [J].
Beig, Avital ;
Miller, Jonathan M. ;
Dahan, Arik .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (02) :386-391
[9]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[10]   The Solubility-Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs [J].
Dahan, Arik ;
Miller, Jonathan M. .
AAPS JOURNAL, 2012, 14 (02) :244-251